Clinical Trials Study
Copyright ©The Author(s) 2020.
World J Transplant. Apr 29, 2020; 10(4): 79-89
Published online Apr 29, 2020. doi: 10.5500/wjt.v10.i4.79
Table 4 Other clinical findings
Control groupStudy groupP value
Duration of procedure44.0 ± 11.044.9 ± 9.80.783
Location of fistula creation-
Dominant1 (5.0%)0 (0.0%)
Non-dominant19 (95.0%)21 (100.0%)
Fistula location
Brachiocephalic12 (60.0%)13 (61.9%)> 0.999
Snuff-box4 (20.0%)4 (19.0%)> 0.999
Radiocephalic3 (15.0%)4 (19.0%)> 0.999
Brachiobasilic1 (5.0%)0 (0.0%)-
Incision length3.0 (2.0-5.0)3.0 (2.0-5.0)0.979
Estimated blood loss42.5 (20.0-120.0)50.0 (10.0-120.0)0.530
VAS4.5 (2.0-10.0)2.0 (1.0-8.0)< 0.001
Willingness to repeat the procedure3.0 (1.0-9.0)8.0 (5.0-10.0)< 0.001
Demand of analgesic9 (45.0%)3 (14.3%)0.069
Amount of local analgesic22.5 (15.0-38.0)20.0 (15.0-40.0)0.607
Anticoagulant14 (70.0%)12 (57.1%)0.596
Beta blocker2 (10.0%)4 (19.0%)0.663
Antihypertensive10 (50.0%)12 (57.1%)0.885